Calixar raises €1 Million

This new round will enable the French biotech company to license-out its isolation technologies for complex therapeutic targets and viral antigens.

Share this post

Secure and boost
your discovery programs.

Starting from native material or recombinant systems, we succeed with all types of membrane proteins: GPCRs, Ion Channels, Transporters, Receptors and Viral Proteins.